...
首页> 外文期刊>Microbiology >Interaction of the transmembrane domain of lysis protein E from bacteriophage ?X174 with bacterial translocase MraY and peptidyl-prolyl isomerase SlyD
【24h】

Interaction of the transmembrane domain of lysis protein E from bacteriophage ?X174 with bacterial translocase MraY and peptidyl-prolyl isomerase SlyD

机译:裂解蛋白E从噬菌体αx174与细菌翻译αx174的相互作用与肽丙二醇和肽基 - 脯氨酰异构酶slyd

获取原文
           

摘要

The molecular target for the bacteriolytic E protein from bacteriophage ?X174, responsible for host cell lysis, is known to be the enzyme phospho-MurNAc-pentapeptide translocase (MraY), an integral membrane protein involved in bacterial cell wall peptidoglycan biosynthesis, with an essential role being played by peptidyl-prolyl isomerase SlyD. A synthetic 37?aa peptide Epep, containing the N-terminal transmembrane α-helix of E, was found to be bacteriolytic against Bacillus licheniformis, and inhibited membrane-bound MraY. The solution conformation of Epep was found by circular dichroism (CD) spectroscopy to be 100?% α-helical. No change in the CD spectrum was observed upon addition of purified Escherichia coli SlyD, implying that SlyD does not catalyse prolyl isomerization upon E. However, Epep was found to be a potent inhibitor of SlyD-catalysed peptidyl-prolyl isomerization (IC50 0.15?μM), implying a strong interaction between E and SlyD. Epep was found to inhibit E. coli MraY activity when assayed in membranes (IC50 0.8?μM); however, no inhibition of solubilized MraY was observed, unlike nucleoside natural product inhibitor tunicamycin. These results imply that the interaction of E with MraY is not at the MraY active site, and suggest that a protein–protein interaction is formed between E and MraY at a site within the transmembrane region.
机译:来自噬菌体βx174的溶硫醇e蛋白的分子靶标,称为宿主细胞裂解的酶,是酶磷酸 - murnac-戊肽磷酸叔肽(MRAY),其参与细菌细胞壁肽聚糖生物合成的整体膜蛋白,具有必要的用肽基 - 脯氨酰异构酶SLYD发挥作用。发现含有N-末端跨膜α-螺旋的合成37?AA肽EPEP,被发现含有对芽孢杆菌的溶杆菌和抑制膜结合的MRAY。通过圆形二色性(CD)光谱法发现EPEP的溶液构象以100?%α-螺旋。在加入纯化的大肠杆菌Slyd时没有观察到CD光谱的变化,暗示SLYD不催化E.然而,发现EPEP是SLYD-催化的肽基 - 脯氨酰异构化的有效抑制剂(IC500.15≤μm ),暗示E和SLYD之间的强烈互动。当在膜中测定时,发现EPEP抑制大肠杆菌MRAY活性(IC500.8≤μm);然而,与核苷天然产物抑制剂undicamycin不同,观察到对溶解的MRAY的抑制。这些结果意味着E与MRAY的相互作用不在MRAY活性部位,并表明在跨膜区的位点在E和MRAY之间形成蛋白质 - 蛋白质相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号